Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000064300

Apexbio Technology LLC CFI-400945 1338806-73-7 10mM (in 1mL DMSO)
SDP

Supplier:  Apexbio Technology LLC C58135.1

Encompass_Preferred

CFI-400945 (CAS 1338806-73-7) is an orally bioavailable inhibitor specifically targeting polo-like kinase 4 (PLK4) a member of the polo-like kinase family involved in centriole duplication and cell cycle control By competitively inhibiting ATP binding to PLK4 CFI-400945 potently suppresses PLK4 catalytic activity (IC50 2 8 nM) and blocks PLK4 autophosphorylation in cellular assays (EC50 12 3 nM) The compound exhibits high selectivity against other polo-like kinases and demonstrates antiproliferative activity in various cancer cell lines Thus CFI-400945 is applied in cancer biology research particularly for studying centrosome regulation and tumor growth inhibition

Catalog No. 50-000-64300


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.